Anemia Clinical Trial
Official title:
Evaluation of a Clinical Decision Support System for Anemia Management in Pre-operative Care: Feasibility & Validation Study
Anemia need to be diagnosed and treated, following several guidelines. However, the
complexity of these recommendations leads to low compliance and to unnecessary and harmful
per- and postoperative blood transfusion.
In order to improve practices and regarding the complexity of the guidelines, the latest
European Consensus Conference recommends the use of decision support systems for the
management of preoperative anemia.
The World Health Organization defines anemia as a hemoglobin level of less than 13 g/dL in
adult men and less than 12 g/dL in women.
The cause of these anemias is most often deficient with 17% iron deficiency. This deficiency
is related to age, inflammatory diseases, blood loss, and absorption disorders mainly. Anemia
must be diagnosed preoperatively and treated.
To reduce transfusion in the perioperative period there are various possibilities: increase
of the preoperative erythrocyte mass, reduction of losses, use of the blood that has been
applied.
The impact of these preoperative strategies can be considerable. In their work, Beattie and
al demonstrates that transfusion is associated with an increase in mortality at 90 days,
proportional to the volume transfused, with certainly a higher risk in fragile subjects. More
recently, an American registry of more than 220,000 patients showed that 30% had preoperative
anemia. This anemia not only significantly increased mortality, but all causes of comorbidity
were aggravated in an anemic patient.
However, the complexity of these recommendations leads to low compliance and to unnecessary
and harmful per- and postoperative blood transfusion.
In order to improve practices and regarding the complexity of the guidelines, the latest
European Consensus Conference recommends the use of decision support systems for the
management of preoperative anemia.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |